CLBT · Cellebrite DI Ltd. Ordinary Shares
View on chartInsiders & Stakes
| Thomas E. Hogan Chief Executive Officer | ▼ Sell | Open Market | 765,249 Shares held | 8/25/2026 | View profile |
| Shiven Ramji Chief Executive Officer | ▲ Buy | Grant | 462,055 Shares held | 9/24/2026 | View profile |
| Marcus Jewell Global Chief Revenue Officer | ▼ Sell | Open Market | 427,128 Shares held | 8/21/2026 | View profile |
| David Barter Chief Financial Officer | ▼ Sell | Open Market | 334,219 Shares held | 7/8/2026 | View profile |
| David Nicholas Gee Chief Marketing Officer | ▼ Sell | Open Market | 135,281 Shares held | 8/24/2026 | View profile |
| Domnitz Yonatan Director | ▲ Buy | Grant | 86,586 Shares held | 9/17/2026 | View profile |
| CLAMMER ADAM Director | ▲ Buy | Grant | 86,586 Shares held | 9/17/2026 | View profile |
| Utsumi Ryusuke Director | ▲ Buy | Grant | 66,586 Shares held | 9/17/2026 | View profile |
| Van Buren Brandon Director | ▲ Buy | Grant | 50,744 Shares held | 9/17/2026 | View profile |
| Baudot-Trajtenberg Nadine Director | ▲ Buy | Grant | 50,744 Shares held | 9/17/2026 | View profile |
| Gruber Dafna Director | ▲ Buy | Grant | 43,109 Shares held | 9/17/2026 | View profile |
| Troy Richardson Director | ▲ Buy | Grant | 36,164 Shares held | 9/17/2026 | View profile |
Transaction History
| Shiven Ramji | ▲ Buy | Grant | 38,505 | $0 | 9/24/2026 |
| Domnitz Yonatan | ▲ Buy | Grant | 15,190 | $0 | 9/17/2026 |
| CLAMMER ADAM | ▲ Buy | Grant | 15,190 | $0 | 9/17/2026 |
| Utsumi Ryusuke | ▲ Buy | Grant | 15,190 | $0 | 9/17/2026 |
| Van Buren Brandon | ▲ Buy | Grant | 15,190 | $0 | 9/17/2026 |
| Baudot-Trajtenberg Nadine | ▲ Buy | Grant | 15,190 | $0 | 9/17/2026 |
| Troy Richardson | ▲ Buy | Grant | 15,190 | $0 | 9/17/2026 |
| Gruber Dafna | ▲ Buy | Grant | 15,190 | $0 | 9/17/2026 |
| Thomas E. Hogan | ▼ Sell | Open Market | 25,299 | $286K | 8/25/2026 |
| David Nicholas Gee | ▼ Sell | Open Market | 4,323 | $49K | 8/24/2026 |
| Marcus Jewell | ▼ Sell | Open Market | 12,562 | $141K | 8/21/2026 |
| David Nicholas Gee | ▼ Sell | Open Market | 2,198 | $25K | 8/21/2026 |
| Thomas E. Hogan | ▼ Sell | Open Market | 139,713 | $2.1M | 8/12/2026 |
| Marcus Jewell | ▼ Sell | Open Market | 411 | $7K | 8/12/2026 |
| David Nicholas Gee | ▼ Sell | Open Market | 230 | $4K | 8/12/2026 |
| Thomas E. Hogan | ▲ Buy | Grant | 339,484 | $0 | 8/11/2026 |
| David Barter | ▼ Sell | Open Market | 41,734 | $683K | 7/8/2026 |
| Thomas E. Hogan | ▼ Sell | Open Market | 103,188 | $1.6M | 7/2/2026 |
| David Nicholas Gee | ▼ Sell | Open Market | 2,243 | $29K | 5/21/2026 |
| David Nicholas Gee | ▼ Sell | Open Market | 3,430 | $45K | 5/21/2026 |
| Marcus Jewell | ▼ Sell | Open Market | 12,658 | $162K | 5/18/2026 |
| David Nicholas Gee | ▼ Sell | Open Market | 228 | $3K | 5/12/2026 |
| Marcus Jewell | ▼ Sell | Open Market | 383 | $5K | 5/12/2026 |
| Shiven Ramji | ▲ Buy | Grant | 423,550 | $0 | 5/12/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
CLBT Featured in Retail Watchlist Amid Cooling Inflation
Cellebrite was included in a Yahoo Finance article listing three US growth tech stocks that retail investors are watching due to cooling inflation. The stock is currently trading near a key support level, with an average analyst target of $15.36. This mention highlights ongoing retail interest in the company's growth potential.
CLBT Featured in Retail Watchlist Amid Cooling Inflation. Cellebrite was included in a Yahoo Finance article listing three US growth tech stocks that retail investors are watching due to cooling inflation. The stock is currently trading near a key support level, with an average analyst target of $15.36. This mention highlights ongoing retail interest in the company's growth potential.